KIT and neoplasm: Genotypically, most GISTs are driven by activating mutations in the tyrosine kinase receptors, KIT and platelet-derived growth factor receptor alpha (PDGFR-α), leading to uncontrolled cell proliferation and tumor growth (Wang et al., 2021).